|1.||Drewes, Asbjørn M: 2 articles (02/2013 - 09/2009)|
|2.||Wong, Gilbert Y: 2 articles (02/2013 - 09/2009)|
|3.||Kell, Sherron: 2 articles (02/2013 - 09/2009)|
|4.||Staahl, Camilla: 2 articles (02/2013 - 09/2009)|
|5.||Arendt-Nielsen, Lars: 2 articles (02/2013 - 09/2009)|
|6.||Olesen, Anne E: 2 articles (02/2013 - 09/2009)|
|7.||Kristensen, Kim: 1 article (02/2013)|
|8.||Dix, Thomas A: 1 article (01/2013)|
|9.||Brower, Justin O: 1 article (01/2013)|
|10.||Woods, R Jeremy: 1 article (01/2013)|
09/01/2009 - "CR665 had a selective effect on visceral pain. "
09/01/2009 - "Compared to placebo, CR665 significantly increased the pain rating threshold to esophageal distension (P < 0.005) but reduced the pain tolerance threshold to skin pinching (P = 0.007). "
01/01/2013 - "In this study we have generated a series of derivatives of CR665 and screened them for oral activity in the acetic acid-induced rat writhing assay for peripheral pain. "
02/01/2013 - "In a randomized, placebo-controlled, double-blind, three-way crossover study, healthy male volunteers were administered CR665 (0.36 mg/kg, intravenous), oxycodone (15 mg, oral) or placebo (intravenous and oral), followed by assessment of visceral pain tolerance thresholds (VPTT) measured as volume of water (mL) in the bag placed on an oesophageal probe. "
09/01/2009 - "Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain."
|2.||Neuralgia (Stump Neuralgia)
|2.||kappa Opioid Receptors (kappa Opioid Receptor)
|3.||Acetic Acid (Vinegar)